Substituted phenethylamine

{{Short description|Chemical class of organic compounds}}

{{More citations needed|date=August 2014}}

{{Use dmy dates|date=December 2014}}

{{cs1 config|name-list-style=vanc|display-authors=6}}

{{Infobox drug class

| Image = Phenylethyl Amine General Formula V1.svg

| ImageClass = skin-invert-image

| Alt = Phenethylamine structure diagram

| Caption = The structural formula of phenethylamine with marked substitution points. Phenethylamine is obtained when
R2=R3=R4=R5=R6=RN=Rα=Rβ=H.

| Use =

| MeshID =

| Biological_target =

| Mechanism_of_action =

| Chemical_class = Substituted derivatives of phenethylamine

}}

Substituted phenethylamines (or simply phenethylamines) are a chemical class of organic compounds that are based upon the phenethylamine structure;{{#tag:ref|In other words, all of the compounds that belong to this class are structural analogs of phenethylamine.|group="note"}} the class is composed of all the derivative compounds of phenethylamine which can be formed by replacing, or substituting, one or more hydrogen atoms in the phenethylamine core structure with substituents. Phenylethylamines are also generally found to be central nervous system stimulants with many also being entactogens/empathogens, and hallucinogens.

Structural classification

File:Phenethylamine2DCSD.svg

The structural formula of any substituted phenethylamine contains a phenyl ring that is joined to an amino (NH) group via a two-carbon sidechain. Hence, any substituted phenethylamine can be classified according to the substitution of hydrogen (H) atoms on phenethylamine's phenyl ring, sidechain, or amino group with a specific group of atoms. Several classes of substances can be considered phenylethylamine derivatives such as Substituted amphetamines, where there is a methyl group substituted at the alpha position on the ethyl chain, Substituted methylenedioxyphenethylamines, where a methylenedioxy group is joined at the 3 and 4 positions on the phenyl ring, and Substituted cathinones, which have a carbonyl group substituted at the beta position on the ethyl chain, most of which also have a methyl group substituted at the alpha positioning making most cathinones substituted amphetamines as well.

Pharmacology

Most substituted phenethylamines are psychoactive drugs which belong to a variety of different drug classes, including central nervous system stimulants (e.g., amphetamine), hallucinogens (e.g., 3,4,5-trimethoxyphenethylamine a.k.a. mescaline), 2,5-dimethoxy-4-methylamphetamine {{aka}} DOM), entactogen (e.g. MDA), appetite suppressants (e.g. phentermine), nasal decongestants and bronchodilators (e.g., levomethamphetamine and pseudoephedrine), antidepressants (e.g. bupropion and phenelzine), antiparkinson agents (e.g., selegiline), and vasopressors (e.g., ephedrine), among others.{{cite journal | vauthors = Inan F, Brunt TM, Contrucci RR, Hondebrink L, Franssen EJ | title = Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review | journal = Therapeutic Drug Monitoring | volume = 42 | issue = 2 | pages = 271–281 | date = April 2020 | pmid = 32022784 | doi = 10.1097/ftd.0000000000000725 }}{{cite book | vauthors = Wills B, Erickson T | chapter = Psychoactive Phenethylamine, Piperazine, and Pyrrolidinophenone Derivatives | editor-last=Barceloux | editor-first=Donald G. | title=Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants | publisher=Wiley | date=9 March 2012 | isbn=978-0-471-72760-6 | doi=10.1002/9781118105955.ch10 | pages=156–192 }} Many of these psychoactive compounds exert their pharmacological effects primarily by modulating monoamine neurotransmitter systems; however, there is no known mechanism of action or biological target that is common to all members of this subclass.{{Medical citation needed|date=February 2016}}

Examples

Numerous endogenous compounds – including hormones, catecholamines such as dopamine and noradrenaline, and many trace amines (e.g. adrenaline, phenethylamine itself, tyramine, thyronamine, and iodothyronamine) – are substituted phenethylamines. Several notable recreational drugs, such as MDPV (Monkey Dust), MDMA (ecstasy), methamphetamine, and cathinone, are also members of the class. Many well-known prescription drugs are from the phenylethylamine class such as Adderall which uses Amphetamine, Desoxyn which uses methamphetamine, and Sudafed which uses pseudoephedrine.

List of substituted phenethylamines

{{Sticky}}

class="wikitable sortable sticky-header" style="font-size:small;"

|+ Selected Phenethylamines

! Structure

! Short Name

! RN

! Rα

! Rβ

! R2

! R3

! R4

! R5

! Full Name

! Biologic activity

File:Meta-Tyramine.svg

| meta-Tyramine

OH3-hydroxyphenethylamineTrace amine
File:Tyramine.svg

| para-Tyramine

OH4-hydroxyphenethylamineTrace amine
File:Dopamine.svg

| Dopamine

OHOH3,4-dihydroxyphenethylamineCatecholamine neurotransmitter
File:Epinephrine.svg

| Epinephrine (Adrenaline)

CH3OHOHOHβ,3,4-trihydroxy-N-methylphenethylamineCatecholamine neurotransmitter/Fight or Flight hormone
File:Norepinephrine.svg

| Norepinephrine (Noradrenaline)

OHOHOHβ,3,4-trihydroxyphenethylamineCatecholamine neurotransmitter/Fight or Flight hormone
File:Norfenefrine.png

| Norfenefrine

OHOHβ,3-dihydroxyphenethylamineTrace amine
File:Octapamine.svg

| para-Octopamine

OHOHβ,4-dihydroxyphenethylamineTrace aminergic α-adrenoceptor agonist
File:6-Hydroxydopamine.svg

| Oxidopamine

OHOHOH2,4,5-trihydroxyphenethylamineneurotoxic agent for the dopamine and norepinephrine receptors
File:Phenylephrine v2.svg

| Phenylephrine

CH3OHOHβ,3-dihydroxy-N-methylphenethylamineα-adrenergic agonist; decongestant
File:Isoprenaline.svg

|Isoprenaline

|CH(CH3)2

|

|OH

|

|OH

|OH

|

|β,3-dihydroxy-N-isopropylphenethylamine

|β-adrenergic agonist; decongestant

File:Salbutamol.svg

| Salbutamol

C(CH3)3OHCH2OHOHβ,4-dihydroxy-3-hydroxymethyl-N-tert-butylphenethylamineShort-action β2-adrenergic agonist
File:Beta-methylphenethylamine.png

| β-Methylphenethylamine

CH3β-methylphenethylamineStimulant
File:Amphetamine.svg

| Amphetamine

CH3α-methylphenethylamineMonoamine releasing agent; Stimulant
File:Methylphenethylamine.png

| N-Methylphenethylamine

CH3N-methylphenethylamineTrace amine; endogenous amphetamine isomer
File:N,N-Dimethylphenethylamine.svg

| {{nowrap|N,N-Dimethylphenethylamine}}

(CH3)2N,N-dimethylphenethylamineTrivial effects (used as a food additive and flavoring agent)
File:Methamphetamine.svg

| Methamphetamine

CH3CH3N-methylamphetamine; N,α-dimethylphenethylamineMonoamine releasing agent; stimulant; neurotoxin
,

|File:Fentermina.svg

| Phentermine

(CH3)2α-methylamphetamine; α,α-dimethylphenethylamineStimulant, anorectic
File:2-methylamphetamine.svg

| Ortetamine

CH3CH32-methylamphetamine; 2,α-dimethylphenethylamineStimulant, anorectic
File:Phenelzine.svg

|Phenelzine

|NH2

|

|

|

|

|

|

|β-phenylethylhydrazine

|Monoamine oxidase inhibitor

File:Tranylcypromine Structure.svg

|Tranylcypromine

|

| colspan="2" | -CH2-

|

|

|

|

|2-phenylcyclopropylamine

|Monoamine oxidase inhibitor

File:Selegiline.svg

|Selegiline

| -CH2-C≡CH

|CH3

|

|

|

|

|

|N,α-dimethyl-N-2-propynylphenethylamine

|MAO-B selective monoamine oxidase inhibitor

File:Methylphenidate-2D-skeletal.svg

| Methylphenidate

colspan=2| -CH2-CH2-CH2-CH2-C(OCH3)=ON,α-butylene-β-methoxycarbonylphenethylamineNDRI; Stimulant
File:Ephedrine-ifa.png

| Ephedrine / Pseudoephedrine

CH3CH3OHN-methyl-β-hydroxyamphetamineReleasing agent; stimulant; decongestant
File:Pseudonorephedrine.png

| Cathine

CH3OHd-β-hydroxyamphetamineModerately selective norepinephrine releasing agent
File:Cathinone.svg

| Cathinone

CH3=Oβ-ketoamphetamineSelective norepinephrine and dopamine releasing agent
File:Methcathinone skeletal.svg

| Methcathinone

CH3CH3=ON-methylcathinoneSelective norepinephrine and dopamine releasing agent
File:Mephedrone-2D-skeletal.svg

| Mephedrone

CH3CH3=OCH34-methylmethcathinoneStimulant, unknown pharmacodynamic actions
File:Ethcathinone.svg

| Ethcathinone

CH2CH3CH3=ON-ethylcathinoneStimulant and norepinephrine releasing agent
File:Amfepramone.svg

| Amfepramone (diethylpropion)

C2H5, C2H5Two ethyl groups attached to the amine groupCH3=ON-diethyl-β-ketoamphetamineAnorectic
File:Bupropion 1.svg

| Bupropion

C(CH3)3CH3=OCl5-chloro-N-tert-butyl-β-ketoamphetamineNDRI
File:3-trifluoromethylamphetamine.svg

| Norfenfluramine

CH3CF33-trifluoromethyl-amphetamineSSRA
File:Fenfluramine2DCSD.svg

| Fenfluramine

CH2CH3CH3CF33-trifluoromethyl-N-ethylamphetamineSSRA
File:5APB.svg

| 5-APB

CH3colspan="2" | -CH=CH-O-5-(2-aminopropyl)benzofuranStimulant, entactogen
File:6APB.svg

| 6-APB

CH3colspan="2" | -O-CH=CH-6-(2-aminopropyl)benzofuranStimulant, entactogen
File:MDA-2D-skeletal.svg

| MDA

CH3colspan="2" | -O-CH2-O-3,4-methylenedioxy-amphetamineStimulant, psychedelic, entactogen
File:MDEA.svg

| MDEA

CH2CH3CH3colspan="2" | -O-CH2-O-3,4-methylenedioxy-N-ethylamphetaminePsychedelic, entactogen, and releasing agent
File:MDMA (simple).svg

| MDMA

CH3CH3colspan="2" | -O-CH2-O-3,4-methylenedioxy-N-methylamphetaminePsychedelic, entactogen, and releasing agent
File:MDMC.svg

| MDMC

CH3CH3=Ocolspan="2" | -O-CH2-O-3,4-methylenedioxymethcathinonePsychedelic, entactogen, and releasing agent
File:5-methoxy-MDA.svg

| MMDA

CH3colspan="2" | -O-CH2-O-OCH35-methoxy-3,4-methylenedioxy-amphetamineStimulant, psychedelic and entactogen
File:MMDMA.svg

| MMDMA

CH3CH3colspan="2" | -O-CH2-O-OCH35-methoxy-3,4-methylenedioxy-N-methylamphetaminePsychedelic, entactogen, and releasing agent
File:Lophophine.png

|Lophophine

colspan="2" | -O-CH2-O-OCH35-methoxy-3,4-methylenedioxyphenethylaminePsychedelic and entactogen
File:Mescaline Structural Formulae bondline.svg

| Mescaline

OCH3OCH3OCH33,4,5-trimethoxyphenethylaminePsychedelic and entactogen
File:Proscaline.svg

| Proscaline

OCH3OCH2CH2CH3OCH32-(3,5-dimethoxy-4-propoxyphenyl)ethanaminePsychedelic and entactogen
File:Metaescaline.svg

| Metaescaline

OCH2CH3OCH3OCH32-(3-ethoxy-4,5-dimethoxyphenyl)ethanaminePsychedelic and entactogen
File:Allylescaline.svg

| Allylescaline

OCH3OCH2CH1CH2OCH34-Allyloxy-3,5-dimethyloxyphenylethylaminePsychedelic and entactogen
File:Methallylescaline.svg

| Methallylescaline

OCH3OCH2C(CH2CH3)OCH34-Methallyloxy-3,5-dimethoxyphenethylaminePsychedelic and entactogen
File:Asymbescaline.png

| Asymbescaline

OCH2CH3OCH2CH3OCH33,4-Diethoxy-5-methoxyphenethylaminePsychedelic and euphoriant
File:2,5-dimethoxy-4-methylamphetamine.svg

| DOM

CH3OCH3CH3OCH32,5-dimethoxy-4-methylamphetaminePsychedelic
File:2,5-dimethoxy-4-bromoamphetamine.svg

| DOB

CH3OCH3BrOCH32,5-dimethoxy-4-bromoamphetaminePsychedelic
File:2,5-dimethoxy-4-chloroamphetamine.svg

| DOC

CH3OCH3ClOCH32,5-dimethoxy-4-chloroamphetaminePsychedelic
File:2,5-dimethoxy-4-iodoamphetamine.svg

| DOI

CH3OCH3IOCH32,5-dimethoxy-4-iodoamphetaminePsychedelic
File:2,5-dimethoxy-4-nitroamphetamine.svg

| DON

CH3OCH3NO2OCH32,5-dimethoxy-4-nitroamphetamineStimulant
File:2C-B.svg

| 2C-B

OCH3BrOCH32,5-dimethoxy-4-bromophenethylaminePsychedelic, stimulant, entactogen and euphoriant
File:Βk-2C-B.svg

| βk-2C-B

=OOCH3BrOCH32,5-dimethoxy-4-bromo-β-ketophenethylaminePsychedelic, stimulant, entactogen and euphoriant
File:2C-C-Chemdraw.png

| 2C-C

OCH3ClOCH32,5-dimethoxy-4-chlorophenethylaminePsychedelic
File:2C-F-Chemdraw.png

| 2C-F

OCH3FOCH32,5-dimethoxy-4-fluorophenethylaminePsychedelic
File:2C-I-Chemdraw.png

| 2C-I

OCH3IOCH32,5-dimethoxy-4-iodophenethylaminePsychedelic, stimulant
File:2C-D-Chemdraw.png

| 2C-D

OCH3CH3OCH32,5-dimethoxy-4-methylphenethylaminePsychedelic, stimulant
File:2C-E-Chemdraw.png

| 2C-E

OCH3CH2-CH3OCH32,5-dimethoxy-4-ethylphenethylaminePsychedelic
File:2C-P-Chemdraw.png

| 2C-P

OCH3CH2-CH3-CH3OCH32,5-dimethoxy-4-propylphenethylamineEntactogen, euphoriant and Psychedelic
File:2C-N 2DACS.svg

| 2C-N

OCH3NO2OCH32,5-dimethoxy-4-nitrophenethylamineeuphoriant
File:2C-O-4-Chemdraw.png

| 2C-O-4

OCH3(CH3)2CHOOCH32,5-Dimethoxy-4-propoxyphenethylamineHallucinogen, psychedelic and entheogenic{{CitePiHKAL}} [http://www.erowid.org/library/books_online/pihkal/pihkal035.shtml 2C-O-4 Entry in PiHKAL]
File:2C-T-2-Chemdraw.png

| 2C-T-2

OCH3S-CH2CH3OCH32,5-dimethoxy-4-ethylthio-phenethylaminePsychedelic
File:2C-T-4-Chemdraw.png

| 2C-T-4

OCH3S-CH(CH3)2OCH32,5-dimethoxy-4-isopropylthio-phenethylaminePsychedelic
File:2C-T-7-Chemdraw.png

| 2C-T-7

OCH3S-CH2CH2CH3OCH32,5-dimethoxy-4-propylthio-phenethylaminePsychedelic
File:2C-T-8-Chemdraw.png

| 2C-T-8

OCH3S-CH2-C3H5OCH32,5-dimethoxy-4-cyclopropylmethylthio-phenethylaminePsychedelic
File:2C-T-19.png

| 2C-T-19

OCH3S-C(CH3)3OCH32,5-dimethoxy-4-tert-butylthio-phenethylaminePsychedelic
File:2C-T-21-Chemdraw.png

| 2C-T-21

OCH3S-CH2-CH2-FOCH32,5-dimethoxy-4-(2-fluoroethylthio)-phenethylaminePsychedelic and euphoriant
File:2C-B-NBOMe-skeletal.svg

| 25B-NBOMe{{cite journal | vauthors = Custodio RJ, Sayson LV, Botanas CJ, Abiero A, You KY, Kim M, Lee HJ, Yoo SY, Lee KW, Lee YS, Seo JW, Ryu IS, Kim HJ, Cheong JH | title = 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential | journal = Addiction Biology | volume = 25 | issue = 6 | pages = e12850 | date = November 2020 | pmid = 31749223 | doi = 10.1111/adb.12850 }}

CH2-C6H4-OCH3OCH3BrOCH32-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:2C-C-NBOMe-skeletal.svg

| 25C-NBOMe

CH2-C6H4-OCH3OCH3ClOCH32-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:25F-NBOMe structure.png

| 25F-NBOMe

CH2-C6H4-OCH3OCH3FOCH32-(4-fluoro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:2C-I-NBOMe-skeletal.svg

| 25I-NBOMe

CH2-C6H4-OCH3OCH3IOCH32-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:25D-NBOMe2DACS.svg

| 25D-NBOMe

CH2-C6H4-OCH3OCH3CH2OCH32-(4-methyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:2C-E-NBOMe 2DACS.svg

| 25E-NBOMe

CH2-C6H4-OCH3OCH3CH2-CH3OCH32-(4-ethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:25P-NBOMe.svg

| 25P-NBOMe

CH2-C6H4-OCH3OCH3CH2-CH3-CH3OCH32-(4-propyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanaminePsychedelic
File:Mescaline-NBOMe.svg

| Mescaline-NBOMe

CH2-C6H4-OCH3OCH3OCH3OCH3N-(2-Methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethanaminePsychedelic
File:25B-NBOH structure.png

|25B-NBOH

CH2–C6H4–OHOCH3BrOCH3N-(2-hydroxybenzyl)-2,5-dimethoxy-4-bromo-phenethylaminePsychedelic
File:NBOH-2CC structure.png

|25C-NBOH

CH2–C6H4–OHOCH3ClOCH3N-(2-hydroxybenzyl)-2,5-dimethoxy-4-chloro-phenethylaminePsychedelic
File:2C-I-NBOH-skeletal.svg

|25I-NBOH

CH2–C6H4–OHOCH3IOCH3N-(2-hydroxybenzyl)-2,5-dimethoxy-4-iodo-phenethylaminePsychedelic
File:25i-NBF.svg

|25I-NBF

CH2–C6H4–FOCH3IOCH3N-(2-fluorobenzyl)-2,5-dimethoxy-4-iodo-phenethylaminePsychedelic
class="sortbottom"

!

! Short Name

! RN

! Rα

! Rβ

! R2

! R3

! R4

! R5

! Full Name

! Biologic activity

Detection

{{Expand section|date=December 2015}}

class="wikitable"

!Method

!Requirement

UV spectrometry

|Reagent needed

Detection of substituted phenethylamines, which include compounds such as 2C-B, MDMA, and other designer drugs, involves various analytical methods aimed at identifying these psychoactive substances. These compounds are structurally similar to amphetamines, making their detection challenging due to potential cross-reactivity in standard drug tests. Techniques like gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and immunoassay screenings are commonly employed for accurate identification. Advanced methods like high-performance liquid chromatography (HPLC) allow for precise separation and quantification of these substances even at low concentrations. Given the rising use of these drugs in recreational settings, developing sensitive and specific detection techniques remains crucial in forensic toxicology and clinical diagnostics.{{fact|date=December 2024}}

Cyclized phenethylamines

There are many cyclized phenethylamines. Examples include the following:

Other cyclized phenethylamines have also been described.{{cite journal | vauthors = Nichols DE | title = Structure-activity relationships of phenethylamine hallucinogens | journal = J Pharm Sci | volume = 70 | issue = 8 | pages = 839–849 | date = August 1981 | pmid = 7031221 | doi = 10.1002/jps.2600700802 | url = https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=f57e387fb5be33822c05b7a3b90888ee717aad21}}{{cite journal | vauthors = Wolters RJ, Bej AJ, Tanner NS | title = Conformationally constrained analogs of mescaline | journal = J Pharm Sci | volume = 63 | issue = 9 | pages = 1379–1382 | date = September 1974 | pmid = 4427260 | doi = 10.1002/jps.2600630909 | url = }}{{cite web | vauthors=Wolters RJ | title=Synthesis of Conformationally Constrained Analogs of Mescaline as Potential Psychotomimetics

| website=ProQuest | url=https://www.proquest.com/openview/35dd826950b4c4799cbe838e814b0a2e/ | access-date=2 June 2025}}

Other related families include phenylpiperazines and benzylpiperazines.

See also

Notes

{{Reflist|group=note}}

References

{{Reflist}}

{{Phenethylamines}}

{{Chemical classes of psychoactive drugs}}

{{Monoamine releasing agents}}

{{Serotonin receptor modulators}}

{{Authority control}}

Category:Chemical classes of psychoactive drugs